A retrospective study of parotid gland tumors at a single institution

Shiori Suzuki, Nobuyuki Bandoh, Takashi Goto, Akinobu Kubota, Akihiro Uemura, Michihisa Kono, Ryosuke Sato, Ryuhei Takeda, Shota Sakaue, Tomomi Yamaguchi-Isochi, Hiroshi Nishihara, Hidehiro Takei, Yasuaki Harabuchi

研究成果: Article査読


The aim of the present study was to analyze the clinical characteristics, surgical treatments and clinical outcome of patients with parotid gland tumors and to compare the results with those cited in the literature. A retrospective study was conducted in 140 patients (male, n=77; female, n=63) with parotid gland tumors who underwent parotidectomy at Hokuto Hospital Department of Otolaryngology-Head and Neck Surgery (Obihiro, Japan) between April 2007 and December 2021. Of the 140 patients enrolled, 118 (84.3%) patients had benign tumors, including 63 (45%) patients with pleomorphic adenomas and 43 (30.7%) patients with Warthin tumors, and 22 patients (15.7%) had parotid carcinoma. Comparison of the three groups of patients with parotid gland tumors indicated that pack years as an indicator of smoking status were signifi‑ cantly higher in patients with Warthin tumors than in those with parotid carcinomas (P=0.011) or pleomorphic adenoma (P<0.001). Fine‑needle aspiration cytology (FNAC) was non‑diagnostic for only 6 (4.3%) of 140 patients. The sensi‑ tivity, specificity, positive predictive value, negative predictive value and accuracy of FNAC by both conventional smear and liquid‑based cytology (LBC) for parotid carcinomas were 70, 99, 93.3, 94.4 and 82.9%, respectively. Among the 22 patients with parotid carcinoma, extended total/total and superficial parotidectomy were performed in 10 (45%) and 11 (50%) cases, respectively. Total and selective neck dissection of the area from level II to I, II and III were performed in 6 (24%) and 7 (32%) patients, respectively. Postoperative radiotherapy (50 Gy) was performed in 15 (68%) patients. The overall survival (OS) and disease‑free survival (DFS) rates at 5 years were 51.5 and 76.4%, respectively. Univariate analysis revealed that age >65 years was significantly associated with poorer 5‑year OS (P<0.001) and DFS (P<0.001). Multivariate analysis revealed that an age of more than 65 years combined with high‑grade histologic malignancy was associated with worse DFS (P=0.02; hazard ratio, 3.628; 95% confidence interval, 1.283-9.514). In conclusion, the clinical characteristics and treatment outcomes of parotid gland tumors were consistent with the results of previous reports. Smoking may be closely related to the pathogenesis of Warthin tumors. LBC potentially provides improved accuracy in FNAC.

ジャーナルOncology Letters
出版ステータスPublished - 2022 7月

ASJC Scopus subject areas

  • 腫瘍学
  • 癌研究


「A retrospective study of parotid gland tumors at a single institution」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。